DK0627004T3 - Forbedringer ved eller i forbindelse med malariavaccine - Google Patents
Forbedringer ved eller i forbindelse med malariavaccineInfo
- Publication number
- DK0627004T3 DK0627004T3 DK93904239T DK93904239T DK0627004T3 DK 0627004 T3 DK0627004 T3 DK 0627004T3 DK 93904239 T DK93904239 T DK 93904239T DK 93904239 T DK93904239 T DK 93904239T DK 0627004 T3 DK0627004 T3 DK 0627004T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- vectors
- sec
- polypeptides
- date
- Prior art date
Links
- 229940124735 malaria vaccine Drugs 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 239000013598 vector Substances 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929203821A GB9203821D0 (en) | 1992-02-22 | 1992-02-22 | Improvements in or relating to malaria vaccine |
| PCT/GB1993/000367 WO1993017107A1 (en) | 1992-02-22 | 1993-02-22 | Improvements in or relating to malaria vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0627004T3 true DK0627004T3 (da) | 2003-05-12 |
Family
ID=10710868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93904239T DK0627004T3 (da) | 1992-02-22 | 1993-02-22 | Forbedringer ved eller i forbindelse med malariavaccine |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5720959A (da) |
| EP (1) | EP0627004B1 (da) |
| JP (1) | JPH07504321A (da) |
| KR (1) | KR100262624B1 (da) |
| AT (1) | ATE231555T1 (da) |
| AU (1) | AU666519B2 (da) |
| CA (1) | CA2128109C (da) |
| DE (1) | DE69332652T2 (da) |
| DK (1) | DK0627004T3 (da) |
| ES (1) | ES2192556T3 (da) |
| GB (1) | GB9203821D0 (da) |
| NZ (1) | NZ249208A (da) |
| WO (1) | WO1993017107A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2697022B1 (fr) * | 1992-10-19 | 1994-12-16 | Pasteur Institut | Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination. |
| FR2744724B1 (fr) * | 1996-02-14 | 2002-08-02 | Pasteur Institut | Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques |
| EP1105487A1 (en) | 1998-08-21 | 2001-06-13 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by The Secretary, Department of Health and Human Services | Recombinant multivalent malarial vaccine against plasmodium falciparum |
| WO2001034188A1 (en) | 1999-11-12 | 2001-05-17 | University Of Hawaii | Malaria vaccine |
| CN1176945C (zh) * | 2001-02-01 | 2004-11-24 | 中国人民解放军第二军医大学 | 疟原虫融合抗原及其制法和用途 |
| US20030104003A1 (en) * | 2001-05-25 | 2003-06-05 | James Anthony A. | Novel surface protein of the malaria parasite plasmodium falciparum |
| EP1885395A4 (en) * | 2005-05-16 | 2009-12-02 | Merck & Co Inc | METHOD FOR INCREASING IMMUNIGENICITY OF PLASMODIUM ANTIGENS |
| US7931908B2 (en) | 2007-02-23 | 2011-04-26 | Philadelphia Health Education Corporation | Chimeric MSP-based malaria vaccine |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3280028D1 (en) * | 1981-05-21 | 1989-12-28 | Wellcome Found | Protozoal antigen |
-
1992
- 1992-02-22 GB GB929203821A patent/GB9203821D0/en active Pending
-
1993
- 1993-02-22 ES ES93904239T patent/ES2192556T3/es not_active Expired - Lifetime
- 1993-02-22 AU AU35704/93A patent/AU666519B2/en not_active Expired
- 1993-02-22 AT AT93904239T patent/ATE231555T1/de not_active IP Right Cessation
- 1993-02-22 CA CA002128109A patent/CA2128109C/en not_active Expired - Lifetime
- 1993-02-22 DK DK93904239T patent/DK0627004T3/da active
- 1993-02-22 JP JP5513568A patent/JPH07504321A/ja active Pending
- 1993-02-22 KR KR1019940702941A patent/KR100262624B1/ko not_active IP Right Cessation
- 1993-02-22 NZ NZ249208A patent/NZ249208A/en not_active IP Right Cessation
- 1993-02-22 US US08/290,919 patent/US5720959A/en not_active Expired - Lifetime
- 1993-02-22 DE DE69332652T patent/DE69332652T2/de not_active Expired - Lifetime
- 1993-02-22 WO PCT/GB1993/000367 patent/WO1993017107A1/en active IP Right Grant
- 1993-02-22 EP EP93904239A patent/EP0627004B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0627004B1 (en) | 2003-01-22 |
| KR100262624B1 (ko) | 2000-08-01 |
| EP0627004A1 (en) | 1994-12-07 |
| ES2192556T3 (es) | 2003-10-16 |
| WO1993017107A1 (en) | 1993-09-02 |
| AU3570493A (en) | 1993-09-13 |
| CA2128109A1 (en) | 1993-09-02 |
| JPH07504321A (ja) | 1995-05-18 |
| GB9203821D0 (en) | 1992-04-08 |
| DE69332652D1 (de) | 2003-02-27 |
| DE69332652T2 (de) | 2003-11-27 |
| CA2128109C (en) | 2007-09-25 |
| NZ249208A (en) | 1996-03-26 |
| KR950700415A (ko) | 1995-01-16 |
| AU666519B2 (en) | 1996-02-15 |
| ATE231555T1 (de) | 2003-02-15 |
| US5720959A (en) | 1998-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL110284A0 (en) | Viral vectors and their use in gene therapy | |
| EP0679716A4 (en) | GENE SIGNATURE. | |
| MX9603002A (es) | Procedimiento para la preparacion de virus asociados a los adenovirus (aav), recombinantes, y usos de los mismos. | |
| FI965031A (fi) | Sieni, jossa AreA-geeni on muunnettu, ja Aspergillus oryzaesta peräisin oleva areA-geeni | |
| EP0681585A4 (en) | FACTORS ASSOCIATED TO TATA-BINDING PROTEINS, NUCLEIC ACIDS ENCODING TAFS AND METHODS FOR USE THEREOF. | |
| ATE181921T1 (de) | Chromatographische isolierung von nucleinsäuren | |
| NO910982L (no) | Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller. | |
| WO1998044104A3 (de) | Flip-gen und flip-protein | |
| WO2001025438A3 (en) | Ifn-alpha homologues | |
| DK0627004T3 (da) | Forbedringer ved eller i forbindelse med malariavaccine | |
| AR015687A2 (es) | Gen aislado que codifica acil transferasa | |
| ATE196926T1 (de) | Gen grb3-3, variante und ihre verwendungen | |
| CA2278808A1 (en) | Methods for cultivating cells and propagating viruses | |
| EP0472399A3 (en) | Hla-dr antigen gene, its nucleotide sequence and its use | |
| DE59712554D1 (de) | Rekombinante expression von s-layer-proteinen | |
| AU3929589A (en) | Human papilloma virus type 57, the dna thereof and the proteins encoded thereby | |
| EP0647138A4 (en) | POLYPEPTIDES AVAILABLE FROM FASCIOLA SPECIES, AND VACCINE, THERAPY PROCEDURES AND DNA SEQUENCES ENCODING THESE PEPTIDES. | |
| AU7357294A (en) | Recombinant cladosporium herbarum allergens | |
| DE69230997D1 (de) | 4-0-methyl-transferas codierende DNA Sequenz | |
| FI971377A0 (fi) | Adenovirusperäisiä virusvektoreita, joissa on kaksi terapeuttista geeniä: itsemurha- ja immuunistimuloiva geeni | |
| ZA916106B (en) | Cloning and expression of a rhoptry-associated protein of p.falciparum | |
| NO974713D0 (no) | Gener som koder for lymfocyttinterferon-regulatorisk faktor (LSIRF) polypeptider | |
| NO981707L (no) | Xylanase, oligonukleotidsekvens som koder for xylanase og anvendelse derav | |
| TW342413B (en) | Novel toxins isolated from Bracon Hebetor | |
| WO2001070808A3 (en) | Angiogenesis - associated proteins, and nucleic acids encoding the same |